How 2026 Painkiller Skips Addiction Entirely

How 2026 Painkiller Skips Addiction Entirely. A 2025 FDA-approved drug called suzetrigine targets NaV1.8 sodium channels in peripheral nerves to relieve acute pain without touching the brain's opioid receptors or reward pathways.With the ongoing opioid crisis and this breakthrough trending as a top 2026 scientific advance, it offers hope for safer pain management and is highly shareable for…